| SC 13D | 2023-11-27 | BISCHOFBERGER NORBERT W | Kronos Bio, Inc. | 10,624,737 | 17.4% | EDGAR |
| SC 13G/A | 2023-07-07 | BlackRock Inc. | Kronos Bio, Inc. | 1,397,345 | 2.4% | EDGAR |
| SC 13G/A | 2023-02-13 | Omega Fund V, L.P. | Kronos Bio, Inc. | 3,818,283 | 6.7% | EDGAR |
| SC 13G/A | 2023-02-13 | Capital World Investors | Kronos Bio, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Kronos Bio, Inc. | 1,504,922 | 2.6% | EDGAR |
| SC 13G/A | 2023-02-01 | BlackRock Inc. | Kronos Bio, Inc. | 3,206,885 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-17 | Belldegrun Arie | Kronos Bio, Inc. | 3,444,889 | 6.1% | EDGAR |
| SC 13G/A | 2022-02-17 | BISCHOFBERGER NORBERT W | Kronos Bio, Inc. | 5,935,160 | 10.5% | EDGAR |
| SC 13G/A | 2022-02-11 | Capital Research Global Investors | Kronos Bio, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2022-02-11 | Capital World Investors | Kronos Bio, Inc. | 3,151,414 | 5.6% | EDGAR |
| SC 13G | 2022-02-10 | VANGUARD GROUP INC | Kronos Bio, Inc. | 3,392,316 | 6.0% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | Kronos Bio, Inc. | 3,369,676 | 6.0% | EDGAR |
| SC 13G | 2021-05-04 | BISCHOFBERGER NORBERT W | Kronos Bio, Inc. | 5,920,804 | 10.6% | EDGAR |
| SC 13G | 2021-02-16 | Capital Research Global Investors | Kronos Bio, Inc. | 3,541,573 | 6.3% | EDGAR |
| SC 13G | 2021-02-12 | Omega Fund V, L.P. | Kronos Bio, Inc. | 3,818,283 | 6.8% | EDGAR |